BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19369334)

  • 1. Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection.
    Shalev Z; Duffy SP; Adema KW; Prasad R; Hussain N; Willett BJ; Tailor CS
    J Virol; 2009 Jul; 83(13):6706-16. PubMed ID: 19369334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus.
    Stewart H; Adema KW; McMonagle EL; Hosie MJ; Willett BJ
    Retrovirology; 2012 May; 9():48. PubMed ID: 22650160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
    Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive mapping of receptor-functioning domains in feline leukemia virus subgroup C receptor FLVCR1.
    Brown JK; Fung C; Tailor CS
    J Virol; 2006 Feb; 80(4):1742-51. PubMed ID: 16439531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Copper Transporter 1 as a Receptor for Feline Endogenous Retrovirus ERV-DC14.
    Tury S; Giovannini D; Ivanova S; Touhami J; Courgnaud V; Battini JL
    J Virol; 2022 Jun; 96(12):e0022922. PubMed ID: 35652657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
    Rigby MA; Rojko JL; Stewart MA; Kociba GJ; Cheney CM; Rezanka LJ; Mathes LE; Hartke JR; Jarrett O; Neil JC
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of thiamine uptake and growth of cells by feline leukemia virus subgroup A.
    Mendoza R; Miller AD; Overbaugh J
    J Virol; 2013 Mar; 87(5):2412-9. PubMed ID: 23269813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Feline Leukemia Virus Interference Group Based on the env Gene.
    Miyake A; Watanabe S; Hiratsuka T; Ito J; Ngo MH; Makundi I; Kawasaki J; Endo Y; Tsujimoto H; Nishigaki K
    J Virol; 2016 May; 90(9):4832-4837. PubMed ID: 26889025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
    Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.
    Hussain N; Thickett KR; Na H; Leung C; Tailor CS
    J Virol; 2011 Dec; 85(23):12529-36. PubMed ID: 21917946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline Leukemia Virus (FeLV) Endogenous and Exogenous Recombination Events Result in Multiple FeLV-B Subtypes during Natural Infection.
    Erbeck K; Gagne RB; Kraberger S; Chiu ES; Roelke-Parker M; VandeWoude S
    J Virol; 2021 Aug; 95(18):e0035321. PubMed ID: 34232703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
    Boomer S; Eiden M; Burns CC; Overbaugh J
    J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma.
    Riedel N; Hoover EA; Gasper PW; Nicolson MO; Mullins JI
    J Virol; 1986 Oct; 60(1):242-50. PubMed ID: 3018287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
    Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
    J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
    Donahue PR; Hoover EA; Beltz GA; Riedel N; Hirsch VM; Overbaugh J; Mullins JI
    J Virol; 1988 Mar; 62(3):722-31. PubMed ID: 2828667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
    Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P
    J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fowler syndrome-associated protein FLVCR2 is an importer of heme.
    Duffy SP; Shing J; Saraon P; Berger LC; Eiden MV; Wilde A; Tailor CS
    Mol Cell Biol; 2010 Nov; 30(22):5318-24. PubMed ID: 20823265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses.
    McDougall AS; Terry A; Tzavaras T; Cheney C; Rojko J; Neil JC
    J Virol; 1994 Apr; 68(4):2151-60. PubMed ID: 8138999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.